false
OasisLMS
Catalog
2025 Gastroenterology Reimbursement and Coding Upd ...
Q&A - Session 3
Q&A - Session 3
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In the final Q&A session of the ASGE 2025 Reimbursement and Coding Update, course directors and presenters addressed a range of topics, focusing prominently on Fibroscan billing, employing pharmacists in gastroenterology practices, digital E&M codes, and denial codes like 237 and their implications. Key points included the consensus (or lack thereof) on Fibroscan billing practices and transitional care management codes. There was also discussion on using modifier 93 for audio-only services and coding for procedures like gastric varices treatment. The collaboration between clinical insights and coding expertise was emphasized as a valuable aspect of the meeting. The session concluded with gratitude to ASGE leadership, participants, and the audience, highlighting the course's commitment to improving practice financial performance and patient care. Participants were reminded to access course recordings and complete evaluations via ASGE's GILeap platform.
Keywords
Fibroscan billing
digital E&M codes
modifier 93
transitional care management
gastric varices treatment
ASGE 2025
×
Please select your language
1
English